227 related articles for article (PubMed ID: 31166033)
21. Hematopoietic Wnts Modulate Endochondral Ossification During Fracture Healing.
Chua K; Lee VK; Chan C; Yew A; Yeo E; Virshup DM
Front Endocrinol (Lausanne); 2021; 12():667480. PubMed ID: 34108937
[TBL] [Abstract][Full Text] [Related]
22. Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide.
Kondo E; Yasoda A; Fujii T; Nakao K; Yamashita Y; Ueda-Sakane Y; Kanamoto N; Miura M; Arai H; Mukoyama M; Inagaki N; Nakao K
Endocrinology; 2015 Jul; 156(7):2518-29. PubMed ID: 25860030
[TBL] [Abstract][Full Text] [Related]
23. Cellular biology of fracture healing.
Bahney CS; Zondervan RL; Allison P; Theologis A; Ashley JW; Ahn J; Miclau T; Marcucio RS; Hankenson KD
J Orthop Res; 2019 Jan; 37(1):35-50. PubMed ID: 30370699
[TBL] [Abstract][Full Text] [Related]
24. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
[TBL] [Abstract][Full Text] [Related]
25. Haploinsufficiency of endogenous parathyroid hormone-related peptide impairs bone fracture healing.
Wang YH; Qiu Y; Han XD; Xiong J; Chen YX; Shi HF; Karaplis A
Clin Exp Pharmacol Physiol; 2013 Nov; 40(11):715-23. PubMed ID: 23937065
[TBL] [Abstract][Full Text] [Related]
26. NR4A1 Regulates Motility of Osteoclast Precursors and Serves as Target for the Modulation of Systemic Bone Turnover.
Scholtysek C; Ipseiz N; Böhm C; Krishnacoumar B; Stenzel M; Czerwinski T; Palumbo-Zerr K; Rothe T; Weidner D; Klej A; Stoll C; Distler J; Tuckermann J; Herrmann M; Fabry B; Goldmann WH; Schett G; Krönke G
J Bone Miner Res; 2018 Nov; 33(11):2035-2047. PubMed ID: 29949664
[TBL] [Abstract][Full Text] [Related]
27. The role of Notch signaling pathway in metabolic bone diseases.
Gao Y; Fu Z; Guan J; Liu X; Zhang Q
Biochem Pharmacol; 2023 Jan; 207():115377. PubMed ID: 36513140
[TBL] [Abstract][Full Text] [Related]
28. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing.
Bergdolt S; Kovtun A; Hägele Y; Liedert A; Schinke T; Amling M; Huber-Lang M; Ignatius A
PLoS One; 2017; 12(6):e0179512. PubMed ID: 28614388
[TBL] [Abstract][Full Text] [Related]
29. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
30. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption.
Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E
J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406
[TBL] [Abstract][Full Text] [Related]
31. Contextual Regulation of Skeletal Physiology by Notch Signaling.
Youngstrom DW; Hankenson KD
Curr Osteoporos Rep; 2019 Aug; 17(4):217-225. PubMed ID: 31069622
[TBL] [Abstract][Full Text] [Related]
32. Increased osteoblast and osteoclast activity in female senescence-accelerated, osteoporotic SAMP6 mice during fracture healing.
Histing T; Stenger D; Kuntz S; Scheuer C; Tami A; Garcia P; Holstein JH; Klein M; Pohlemann T; Menger MD
J Surg Res; 2012 Jun; 175(2):271-7. PubMed ID: 21571305
[TBL] [Abstract][Full Text] [Related]
33. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
[TBL] [Abstract][Full Text] [Related]
34. CTRP3 Regulates Endochondral Ossification and Bone Remodeling During Fracture Healing.
Youngstrom DW; Zondervan RL; Doucet NR; Acevedo PK; Sexton HE; Gardner EA; Anderson JS; Kushwaha P; Little HC; Rodriguez S; Riddle RC; Kalajzic I; Wong GW; Hankenson KD
J Orthop Res; 2020 May; 38(5):996-1006. PubMed ID: 31808575
[TBL] [Abstract][Full Text] [Related]
35. TNF and Bone Remodeling.
Zhao B
Curr Osteoporos Rep; 2017 Jun; 15(3):126-134. PubMed ID: 28477234
[TBL] [Abstract][Full Text] [Related]
36. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
[TBL] [Abstract][Full Text] [Related]
37. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms in coupling of bone formation to resorption.
Martin T; Gooi JH; Sims NA
Crit Rev Eukaryot Gene Expr; 2009; 19(1):73-88. PubMed ID: 19191758
[TBL] [Abstract][Full Text] [Related]
39. Osteoclasts and Remodeling Based Bone Formation.
Kylmaoja E; Nakamura M; Tuukkanen J
Curr Stem Cell Res Ther; 2016; 11(8):626-633. PubMed ID: 26477623
[TBL] [Abstract][Full Text] [Related]
40. Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
Kalaitzoglou E; Popescu I; Bunn RC; Fowlkes JL; Thrailkill KM
Curr Osteoporos Rep; 2016 Dec; 14(6):310-319. PubMed ID: 27704393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
